MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
Masimo Corporation DSO Ratio 2011-2026 | MASI
Annual DSO Ratio Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 12.7 | 22.6 | - | 64.9 | 51 | 59.6 | 51.3 | 48.9 | - | 56.1 | 55.5 | 55.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.9 | 12.7 | 47.8 |
Quarterly DSO Ratio Masimo Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.2 | - | - | - | - | - | - | - | 92.2 | - | - | - | 62.1 | - | 44.6 | 51.2 | 51.4 | 55 | 46.9 | 20.5 | - | 53.4 | 50.3 | 48.3 | 48.5 | 52.4 | 52.6 | 47.7 | 43.1 | 45.6 | 47.3 | 48.9 | 52 | 55.9 | 56.2 | 51.1 | 48.8 | 53.4 | 53.7 | 46 | 41.3 | 44.6 | 41.6 | 20.1 | - | 47 | 48.4 | 49.2 | 47.1 | 51 | 51 | 48.5 | 45.2 | 50.2 | 50.5 | 47.8 | 46.3 | 50 | 47.5 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.2 | 20.1 | 49.2 |
DSO Ratio of other stocks in the Medical instruments industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
68.9 | $ 60.79 | 0.68 % | $ 12.1 B |  USA |
 |
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
38 | $ 115.17 | 0.88 % | $ 3.69 B | USA |
 |
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
29.7 | $ 121.75 | -1.01 % | $ 3 B | USA |
 |
Repro Med Systems
KRMD
|
52.9 | $ 3.89 | -2.26 % | $ 180 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
49.9 | $ 426.62 | -0.34 % | $ 152 B | USA |
 |
LeMaitre Vascular
LMAT
|
42.9 | $ 99.14 | -0.36 % | $ 2.24 B | USA |
 |
Alcon
ALC
|
71 | $ 64.53 | 0.8 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
207 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
53.2 | $ 23.88 | 0.13 % | $ 4.01 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
13.6 | $ 6.3 | -2.02 % | $ 53.4 K | USA |
 |
Haemonetics Corporation
HAE
|
54.9 | $ 56.86 | -0.4 % | $ 2.86 B | USA |
 |
STAAR Surgical Company
STAA
|
38.2 | $ 31.88 | -0.42 % | $ 1.58 B | USA |
 |
STERIS plc
STE
|
68.6 | $ 215.75 | -0.17 % | $ 21.3 B | USA |
 |
Teleflex Incorporated
TFX
|
184 | $ 130.11 | -0.13 % | $ 5.81 B | USA |
 |
Isoray
ISR
|
353 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
44 | $ 142.59 | 0.3 % | $ 6.91 B | USA |
 |
InfuSystem Holdings
INFU
|
56.1 | $ 8.53 | -1.24 % | $ 176 M | USA |
 |
Microbot Medical
MBOT
|
167 | $ 1.92 | 3.51 % | $ 87.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
9.67 | $ 0.34 | -0.15 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
47.4 | $ 62.51 | -0.08 % | $ 3.7 B | USA |
 |
Utah Medical Products
UTMD
|
154 | $ 63.24 | -0.72 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
66.9 | $ 302.94 | 0.92 % | $ 21.9 B | USA |
 |
Pulse Biosciences
PLSE
|
143 | $ 24.97 | -7.88 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
64.3 | $ 10.04 | -3.6 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
74.8 | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
83.1 | $ 59.29 | 1.09 % | $ 195 M | USA |
 |
Predictive Oncology
POAI
|
96.5 | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
31.2 | $ 20.77 | -1.36 % | $ 992 M | USA |
 |
Stereotaxis
STXS
|
54.5 | $ 1.88 | -3.34 % | $ 171 M | USA |
 |
Baxter International
BAX
|
52.6 | $ 17.56 | -1.29 % | $ 9.01 B | USA |
 |
ResMed
RMD
|
60.7 | $ 204.64 | 1.03 % | $ 29.9 B | USA |
 |
AtriCure
ATRC
|
43.4 | $ 28.64 | 1.72 % | $ 1.37 B | USA |
 |
Harvard Bioscience
HBIO
|
65.2 | $ 5.48 | -0.69 % | $ 243 M | USA |
 |
NeuroMetrix
NURO
|
42.8 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
54 | $ 11.01 | -0.18 % | $ 450 M | USA |
 |
Becton, Dickinson and Company
BDX
|
50.4 | $ 143.69 | -0.57 % | $ 41.3 B | USA |
 |
Nephros
NEPH
|
40.7 | $ 3.21 | -3.94 % | $ 34.1 M | USA |
 |
OraSure Technologies
OSUR
|
73 | $ 3.04 | 3.05 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
72.4 | $ 105.54 | 2.09 % | $ 5.93 M | USA |